Abstract:To enhance the glucose sensitivity and self-regulated release of insulin, biobased capsules with glucose-responsive and competitive properties were fabricated based on poly(γ-glutamic acid) (γ-PGA) and chitosan oligosaccharide (CS) polyelectrolytes. First, poly(γ-glutamic acid)-g-3-aminophenylboronic acid) (γ-PGA-g-APBA) and galactosylated chitosan oligosaccharide (GC) were synthesized by grafting APBA and lactobionic acid (LA) to γ-PGA and CS, respectively. The (γ-PGA-g-APBA/GC)5 capsules were then prepared by layer-by-layer (LBL) assembly of γ-PGA-g-APBA and GC via electrostatic interaction. The size and morphology of the particles and capsules were investigated by DLS, SEM, and TEM. The size of the (γ-PGA-g-APBA/GC)5 capsules increased with increasing glucose concentration due to the swelling of the capsules. The capsules could be dissociated at high glucose concentration due to the breaking of the cross-linking bonds between APBA and LA by the competitive reaction of APBA with glucose. The encapsulated insulin was able to undergo self-regulated release from the capsules depending on the glucose level and APBA composition. The amount of insulin release increased with incubation in higher glucose concentration and decreased with higher APBA composition. Moreover, the on-off regulation of insulin release from the (γ-PGA-g-APBA/GC)5 capsules could be triggered with a synchronizing and variation of the external glucose concentration, whereas the capsules without the LA functional groups did not show the on-off regulated release. Furthermore, the (γ-PGA-g-APBA/GC)5 capsules are biocompatible. These (γ-PGA-g-APBA/GC)5 with good stability, glucose response, and controlled insulin delivery are expected to be used for future applications to glucose-triggered insulin delivery.

A Glucose-Responsive Controlled Release of Insulin System Based on Enzyme Multilayers-Coated Mesoporous Silica Particles.

Stimuli-responsive Functionalized Mesoporous Silica Nanoparticles for Drug Release in Response to Various Biological Stimuli

Phenylboronic Acid Functionalized Silica Nanoparticles with Enlarged Ordered Mesopores for Efficient Insulin Loading and Controlled Release

A glucose-responsive controlled release system using glucose oxidase-gated mesoporous silica nanocontainers.

Synthesis and testing of polymer grafted mesoporous silica as glucose-responsive insulin release drug delivery systems

Glucose-Responsive Peptide Coacervates with High Encapsulation Efficiency for Controlled Release of Insulin.

Preparation of Dendritic Mesoporous Silica/Phenylboronic Acid-Modified Hydroxypropyl Chitosan and Its Glucose-Responsive Performance

Bio-Inspired Synthetic Nanovesicles for Glucose-Responsive Release of Insulin

Glucose-Responsive Supramolecular Vesicles Based on Water-Soluble Pillar[5]arene and Pyridylboronic Acid Derivatives for Controlled Insulin Delivery

Glucose-responsive Microgels Integrated with Enzyme Nanocapsules for Closed-Loop Insulin Delivery.

Glucose-regulated Insulin Release from Acid-Disintegrable Microgels Covalently Immobilized with Glucose Oxidase and Catalase.

Multiresponsive Supramolecular Theranostic Nanoplatform Based on Pillar[5]arene and Diphenylboronic Acid Derivatives for Integrated Glucose Sensing and Insulin Delivery

Controlled Release of Insulin Based on Temperature and Glucose Dual Responsive Biomicrocapsules

Fabrication of Biobased Polyelectrolyte Capsules and Their Application for Glucose-Triggered Insulin Delivery.

Chitosan Hydrogel‐Capped Porous SiO2 As a Ph Responsive Nano‐Valve for Triggered Release of Insulin

Glucose‐Responsive Charge‐Switchable Lipid Nanoparticles for Insulin Delivery

Polysaccharide-Based Nanoparticles Equipped with Glucose Oxidase for in Vivo Insulin Delivery

All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery.

Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery

H2O2-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery.

Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery